Medical Glove Chemical Resistance: ASTM D6978 Testing Explained
A compounding pharmacist in Mississauga assumed any nitrile glove rated for exams would protect her staff while preparing hazardous drugs. It did not. When she checked the chemotherapy permeation data on the glove boxes in her dispensary, most of them had never been tested against the drugs she handled. The difference between an exam glove and a chemotherapy glove is not marketing — it is a specific ASTM test that most gloves never take.
Why Chemical Resistance Is a Separate Test From Barrier Quality
An examination glove passes ASTM D6319 if it resists punctures and stretches without tearing. That tells you the glove will hold up during a physical exam. It says nothing about what happens when a solvent, a hazardous drug, or a disinfectant contacts the glove surface and starts migrating through the polymer. Chemical resistance is measured separately, and the test that matters most for Canadian healthcare buyers is ASTM D6978.
ASTM D6978, Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs, exposes a glove material sample to a panel of chemotherapy agents under controlled conditions and measures breakthrough time. If a glove does not carry a D6978 claim, it has not been verified against chemotherapy permeation. For pharmacies, oncology clinics, and labs handling hazardous compounds, that documentation gap is a liability.
Exam Gloves vs Chemotherapy Gloves: The Practical Difference
Exam-grade nitrile is fine for routine clinical contact — blood draws, wound care, cleaning. Chemotherapy gloves are built and validated for a different failure mode: slow permeation of drug molecules through the glove wall over minutes of contact. The distinction matters because hazardous drug exposure is cumulative, and gloves are the primary barrier between the clinician and the compound.

USP General Chapter <800> in the United States and Health Canada's guidance on hazardous drugs both push toward dedicated gloves for compounding and administration. Canadian facilities that follow these frameworks need a glove with documented D6978 testing, not a generic exam box.
What to Look For on the Box
Four details separate a chemotherapy glove from a lookalike:
A D6978 claim printed on the packaging or technical data sheet. The list of drugs tested, because a claim validated against one drug panel is not universal. A thickness statement — most chemotherapy gloves sit at 4.0 mil or above, since thicker polymer slows permeation. A powder-free, latex-free formulation, because powder can carry drug residue and latex allergy adds clinical risk.

CliniEco Medical carries the Aurelia Protege 4.0mil chemotherapy-grade nitrile glove for dispensaries and oncology settings, alongside standard 4mil exam gloves for routine clinical work. Keeping the two lines separate on the shelf — and in the purchase order — prevents the exact mix-up that puts staff at risk.
Disinfectant and Solvent Contact: The Other Chemical Risk
Chemotherapy is not the only chemical exposure gloves face. Clinic staff wipe counters with quaternary ammonium disinfectants, handle alcohol prep pads, and clean instruments with enzymatic solutions. Repeated contact with solvents degrades glove polymer over time, even when a single exposure seems harmless. For tasks involving prolonged solvent contact, rotating to a thicker 6mil heavy-duty nitrile glove and changing it more frequently reduces permeation risk.
When a facility standardizes glove selection by task — exam gloves for patient contact, chemotherapy gloves for hazardous compounding, heavy-duty nitrile for cleaning — the purchasing conversation becomes simpler. One supplier, documented standards, and a clear policy for which glove goes with which task.
Frequently Asked Questions
What does ASTM D6978 measure?
It measures how quickly chemotherapy drugs permeate through a glove material under controlled laboratory conditions. Gloves that pass are documented for use when handling hazardous drugs.
Are all nitrile gloves chemotherapy-resistant?
No. Most nitrile exam gloves are never tested against chemotherapy drugs. A D6978 claim on the box or technical sheet is the only way to know the glove was validated for that exposure.
Can I use chemotherapy gloves for routine exams?
Technically yes, but it wastes cost and thicker gloves reduce tactile sensitivity. Most facilities reserve chemotherapy gloves for compounding and drug administration, and use standard exam gloves for routine contact.
Does Health Canada require D6978 gloves for compounding?
Health Canada's hazardous drug guidance emphasizes engineering controls and personal protective equipment including appropriate gloves. Facilities handling hazardous drugs are expected to use gloves validated against permeation, which in practice means D6978-tested products.
How often should compounding staff change chemotherapy gloves?
Follow the glove manufacturer's stated breakthrough time and change after each compounding task or every 30 minutes of continuous contact, whichever comes first. Gloves are single-use in compounding.
Review your dispensary's glove boxes before the next order. If the packaging does not cite D6978, your staff may be wearing an exam glove for a chemotherapy task. Order the Aurelia Protege chemotherapy-grade glove from CliniEco Medical and close that gap.
Related Reading
Explore more guides in this category:
0 comments